Potomac Fund Management Inc /Adv Amgen Inc Transaction History

Potomac Fund Management Inc /Adv

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Oct 02, 2025	BUY	$262.28 - $309.85 $69,241 - $81,800	264 Added 14.24%	2,118 $633 Million
Q2 2025 Aug 14, 2025	BUY	$262.28 - $309.85 $555,509 - $656,262	2,118 New	2,118 $633 Million
Q4 2024 Oct 02, 2025	SELL	$258.78 - $328.31 $68,317 - $86,673	-264 Reduced 12.46%	1,854 $483 Million
Q4 2024 Feb 12, 2025	BUY	$258.78 - $328.31 $479,778 - $608,686	1,854 New	1,854 $483 Million

3,301

428M

6.12M

5.85M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Potomac Fund Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Potomac Fund Management Inc /Adv with notifications on news.